RxDoctor Payments Data

Andrew Lin

Dermatology · Seattle, WANPI 1457694598

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (40.0%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Lilly USA, LLC at 48.2% of the total. Reporting peaked in 2022 at $16,333 and has fallen 97.3% since, to $440 in 2024. Among dermatology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,763in general payments, 2019–2025

Across 290 payments — averaging $64.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$9K
  • AbbVie$6K
  • E.r. Squibb & Sons, L.L.C.$707
  • Amgen$461
  • Regeneron Healthcare Solutions, Inc.$276
  • Pfizer$229
  • plus $2K from 16 others

What the payments were for

  • Consulting fees$3,15017%
  • Speaking & faculty fees$7,50040%
  • Travel & lodging$1,98111%
  • Food & beverage$6,03232%
  • Education$991%

General payments by program year

20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,763 in reported general payments places this provider in the 95th percentile of 323 dermatology providers in Washington.

See all dermatology providers in Washington

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab25$91,702
AdbryTralokinumab-Ldrm11$40,585
Fluorouracil59$2,631
Ketoconazole83$1,676
Tacrolimus20$1,655
Triamcinolone Acetonide54$1,416
Clobetasol Propionate51$1,298
Hydrocortisone29$1,002
Doxycycline Monohydrate20$598
Fluocinonide28$547

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
LEO Pharma Inc.Adbry$140$40,58511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 323 dermatology providers in Washington.

Other dermatology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →